Erratum: EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice (Blood (2015) 125: 18 (2845-2854) DOI: 10.1182/blood-2014-11-610717);EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice

Blood

Volumn 125, Issue 18, 2015, Pages 2845-2854

  Liang, Hai Po H ^a,d   Kerschen, Edward J ^a   Hernandez, Irene ^a   Basu, Sreemanti ^a   Zogg, Mark ^a   Botros, Fady ^a   Jia, Shuang ^b   Hessner, Martin J ^b   Griffin, John H ^c   Ruf, Wolfram ^c   Weiler, Hartmut ^a,b,c  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Epcr par2 signaling regulates myeloid cell tlr4 responses independent of coagulation.

Indexed keywords

ADAPTOR PROTEIN; ANTICOAGULANT PROTEIN; ENDOTHELIAL PROTEIN C RECEPTOR; GBP2 PROTEIN; GBP3 PROTEIN; GBP6 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IIGP1 PROTEIN; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; LIF PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1; NEMATODE ANTICOAGULANT PROTEIN 5; NEMATODE ANTICOAGULANT PROTEIN C2; PELLINO 1 PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; PROTEINASE ACTIVATED RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR; CELL SURFACE RECEPTOR; PROCR PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BONE MARROW CELL; BONE MARROW DERIVED MYELOID CELL; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAW 264.7 CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; ENDOTOXEMIA; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CELLS, CULTURED; ENDOTOXEMIA; GENE EXPRESSION REGULATION; INTERFERONS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, PAR-2; RECEPTORS, CELL SURFACE;

EID: 84946801346     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2018-04-845123     Document Type: Erratum

References (53)

1. Pawlinski R, Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res. 2010;125(Suppl 1):S70-S73.
2. Mohan Rao LV, Esmon CT, Pendurthi UR. Endothelial cell protein C receptor: a multiliganded and multifunctional receptor. Blood. 2014;124(10): 1553-1562.
3. Bouwens EA, Stavenuiter F, Mosnier LO. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway. J Thromb Haemost. 2013;11(Suppl 1):242-253.
4. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34-45.
5. Esmon CT. Protein C anticoagulant system-antiinflammatory effects. Semin Immunopathol. 2012; 34(1):127-132.
6. Zheng X, Li W, Song Y, et al. Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia. J Thromb Haemost. 2007;5(7):1394-1400.
7. Kerschen E, Hernandez I, Zogg M, et al. Activated protein C targets CD81 dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest. 2010;120(9):3167-3178.
8. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204(10):2439-2448.
9. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 1996;381(6582):516-519.
10. Darrow AL, Fung-Leung WP, Ye RD, et al. Biological consequences of thrombin receptor deficiency in mice. Thromb Haemost. 1996;76(6): 860-866.
11. Li W, Zheng X, Gu JM, et al. Extraembryonic expression of EPCR is essential for embryonic viability. Blood. 2005;106(8):2716-2722.
12. Lindner JR, Kahn ML, Coughlin SR, et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol. 2000; 165(11):6504-6510.
13. Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature. 2001;413(6851):74-78.
14. Parry GC, Erlich JH, Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest. 1998;101(3):560-569.
15. Pawlinski R, Tencati M, Holscher T, et al. Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost. 2007;5(8):1693-1700.
16. Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest. 2011;121(7):2932-2944.
17. Monestier M, Fasy TM, Losman MJ, Novick KE, Muller S. Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Mol Immunol. 1993;30(12): 1069-1075.
18. Bhattacharjee G, Ahamed J, Pedersen B, et al. Regulation of tissue factor-mediated initiation of the coagulation cascade by cell surface grp78. Arterioscler Thromb Vasc Biol. 2005;25(8): 1737-1743.
19. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223(1):77-92.
20. Bucci M, Vellecco V, Harrington L, et al. Crosstalk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function. Br J Pharmacol. 2013;168(2):411-420.
21. Rallabhandi P, Nhu QM, Toshchakov VY, et al. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J Biol Chem. 2008; 283(36):24314-24325.
22. Disse J, Petersen HH, Larsen KS, et al. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem. 2011;286(7):5756-5767.
23. Disse J, Ruf W. Endothelial protein C receptor is required for tissue factor ternary complex signaling in the mouse. J Thromb Haemost. 2011; 9(12):2516-2518.
24. Larsen KS, Ostergaard H, Olsen OH, Bjelke JR, Ruf W, Petersen LC. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2. J Biol Chem. 2010;285(26):19959-19966.
25. Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem. 2004;279(22): 23038-23044.
26. Dror N, Alter-Koltunoff M, Azriel A, et al. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol Immunol. 2007; 44(4):338-346.
27. Berghout J, Langlais D, Radovanovic I, et al. Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog. 2013;9(7):e1003491.
28. Marquis JF, Kapoustina O, Langlais D, et al. Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet. 2011;7(6): e1002097.
29. Yamamoto M, Okuyama M, Ma JS, et al. A cluster of interferon-g-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity. 2012;37(2):302-313.
30. Ferreyra GA, Elinoff JM, Demirkale CY, et al. Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality. PLoS ONE. 2014;9(2):e88756.
31. Fields RC, Schoenecker JG, Hart JP, Hoffman MR, Pizzo SV, Lawson JH. Protease-activated receptor-2 signaling triggers dendritic cell development. Am J Pathol. 2003;162(6): 1817-1822.
32. Moynagh PN. The roles of Pellino E3 ubiquitin ligases in immunity. Nat Rev Immunol. 2014; 14(2):122-131.
33. Weighardt H, Jusek G, Mages J, et al. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur J Immunol. 2004;34(2):558-564.
34. Sikorski K, Chmielewski S, Olejnik A, et al. STAT1 as a central mediator of IFNg and TLR4 signal integration in vascular dysfunction. JAK-STAT. 2012;1(4):241-249.
35. Kanno Y, Levi BZ, Tamura T, Ozato K. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interferon Cytokine Res. 2005;25(12):770-779.
36. Tailor P, Tamura T, Kong HJ, et al. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity. 2007;27(2):228-239.
37. Schiavoni G, Mattei F, Sestili P, et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(1) dendritic cells. J Exp Med. 2002;196(11):1415-1425.
38. Becker AM, Michael DG, Satpathy AT, Sciammas R, Singh H, Bhattacharya D. IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood. 2012;119(9): 2003-2012.
39. Cuenca AG, Delano MJ, Kelly-Scumpia KM, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med. 2011; 17(3-4):281-292.
40. Ray A, Chakraborty K, Ray P. Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front Cell Infect Microbiol. 2013;3: 52.
41. Waight JD, Netherby C, Hensen ML, et al. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J Clin Invest. 2013;123(10):4464-4478.
42. Alabanza LM, Esmon NL, Esmon CT, Bynoe MS. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells. J Immunol. 2013;191(7): 3764-3777.
43. Srinivasan R, Ozhegov E, van den Berg YW, et al. Splice variants of tissue factor promote monocyteendothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost. 2011;9(10):2087-2096.
44. Schoenmakers SH, Groot AP, Florquin S, Reitsma PH, Spek CA. Blood cell-derived tissue factor influences host response during murine endotoxemia. Blood Cells Mol Dis. 2004;32(2): 325-333.
45. de Bruin AM, Libregts SF, Valkhof M, Boon L, Touw IP, Nolte MA. IFNg induces monopoiesis and inhibits neutrophil development during inflammation. Blood. 2012;119(6):1543-1554.
46. Rijneveld AW, Weijer S, Bresser P, et al. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med. 2006;34(6): 1725-1730.
47. Weijer S, Schoenmakers SH, Florquin S, et al. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis. 2004;189(12):2308-2317.
48. Xiao Y, Jin J, Chang M, et al. Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. Nat Med. 2013; 19(5):595-602.
49. Turcotte K, Gauthier S, Malo D, Tam M, Stevenson MM, Gros P. Icsbp1/IRF-8 is required for innate and adaptive immune responses against intracellular pathogens. J Immunol. 2007; 179(4):2467-2476.
50. Turner L, Lavstsen T, Berger SS, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013; 498(7455):502-505.
51. Fairfax BP, Humburg P, Makino S, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science. 2014;343(6175):1246949.
52. Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011;365(2): 127-138.
53. Salem S, Gros P. Genetic determinants of susceptibility to Mycobacterial infections: IRF8, a new kid on the block. Adv Exp Med Biol. 2013; 783:45-80.